Evidence map›Paper›PMID 32209622›Full record

ArticleBMJ open2020

Severe Asthma Toolkit: an online resource for multidisciplinary health professionals-needs assessment, development process and user analytics with survey feedback.

Steven Maltby, Peter G Gibson, Helen K Reddel, Lorraine Smith, Peter A B Wark, Gregory G King, John W Upham, Vanessa L Clark, Mark Hew, Louisa Owens and 5 more

Abstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Steven MaltbyNHMRC Centre of Excellence in Severe Asthma, New Lambton, New South Wales, Australia.ORCID 0000-0003-1240-5964
Peter G GibsonNHMRC Centre of Excellence in Severe Asthma, New Lambton, New South Wales, Australia.
Helen K ReddelNHMRC Centre of Excellence in Severe Asthma, New Lambton, New South Wales, Australia.
Lorraine SmithNHMRC Centre of Excellence in Severe Asthma, New Lambton, New South Wales, Australia.
Peter A B WarkNHMRC Centre of Excellence in Severe Asthma, New Lambton, New South Wales, Australia.
Gregory G KingNHMRC Centre of Excellence in Severe Asthma, New Lambton, New South Wales, Australia.
John W UphamNHMRC Centre of Excellence in Severe Asthma, New Lambton, New South Wales, Australia.
Vanessa L ClarkNHMRC Centre of Excellence in Severe Asthma, New Lambton, New South Wales, Australia.
Mark HewDepartment of Allergy, Immunology & Respiratory Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
Louisa OwensSydney Children's Hospital, Sydney, New South Wales, Australia.
Stephen OoPrincess Margaret Hospital, Fiona Stanley Hospital and University of Western Australia, Perth, New South Wales, Australia.
Alan L JamesNHMRC Centre of Excellence in Severe Asthma, New Lambton, New South Wales, Australia.
Bruce ThompsonNHMRC Centre of Excellence in Severe Asthma, New Lambton, New South Wales, Australia.
Guy B MarksNHMRC Centre of Excellence in Severe Asthma, New Lambton, New South Wales, Australia.
Vanessa M McDonaldNHMRC Centre of Excellence in Severe Asthma, New Lambton, New South Wales, Australia Vanessa.McDonald@newcastle.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSevere asthma imposes a significant burden on individuals, families and the healthcare system. New treatment and management approaches are emerging as effective options for severe asthma. Translating new knowledge to multidisciplinary healthcare professionals is a priority. We developed 'The Severe Asthma Toolkit' (https://toolkit.severeasthma.org.au) to increase awareness of severe asthma, provide evidence-based resources and support decisionmaking by healthcare providers.

settingRoundtable discussions and a survey of Australians clinicians were conducted to determine clinician preferences, format and content for a severe asthma resource.

participantsA reference group from stakeholder and consumer bodies and severe asthma experts provided advice and feedback. A multidisciplinary team of international experts was engaged to develop content. Written content was based on up-to-date literature. Peer and editorial review were performed to finalise content and inform web design. Website design focused on user experience, navigation, engagement, interactivity and tailoring of content for a clinical audience.

resultsA web-based resource was developed. Roundtable discussions and a needs assessment survey identified the need for dedicated severe asthma management resources to support skills training. The end-product, which launched 26 March 2018, includes an overview of severe asthma, diagnosis and assessment, management, medications, comorbidities, living with severe asthma, establishing a clinic, paediatrics/adolescents and clinical resources. Analytics indicate access by users worldwide (32 169 users from 169 countries). User survey results (n=394) confirm access by the target audience (72% health professionals), who agreed the toolkit increased their knowledge (73%) and confidence in managing severe asthma (66%), and 75% are likely to use the resource in clinic.

conclusionsThe Severe Asthma Toolkit is a unique, evidence-based internet resource to support healthcare professionals providing optimal care for people with severe asthma. It is a comprehensive, accessible and independent resource developed by leading severe asthma experts to improve clinician knowledge and skills in severe asthma management.

Indexed as

Decision Support Systems, ClinicalPatient Care TeamSoftwareAsthmaHumansInternetNeeds AssessmentPractice Guidelines as Topicasthmaclinical resourceeducation

Identifiers

PMID32209622
PMCPMC7202709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.